These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 15880743
21. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity. Liang ZQ, Wang XX, Wang Y, Chuang DM, DiFiglia M, Chase TN, Qin ZH. Neurobiol Dis; 2005 Nov; 20(2):562-73. PubMed ID: 15922606 [Abstract] [Full Text] [Related]
22. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters. Estrada-Sánchez AM, Montiel T, Segovia J, Massieu L. Neurobiol Dis; 2009 Apr; 34(1):78-86. PubMed ID: 19168136 [Abstract] [Full Text] [Related]
28. Characterization of striatal cultures with the effect of QUIN and NMDA. Kumar U. Neurosci Res; 2004 May; 49(1):29-38. PubMed ID: 15099701 [Abstract] [Full Text] [Related]
29. Influence of CGS 21680, a selective adenosine A(2A) receptor agonist, on NMDA receptor function and expression in the brain of Huntington's disease mice. Ferrante A, Martire A, Armida M, Chiodi V, Pézzola A, Potenza RL, Domenici MR, Popoli P. Brain Res; 2010 Apr 06; 1323():184-91. PubMed ID: 20138162 [Abstract] [Full Text] [Related]
30. Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. Desplats PA, Kass KE, Gilmartin T, Stanwood GD, Woodward EL, Head SR, Sutcliffe JG, Thomas EA. J Neurochem; 2006 Feb 06; 96(3):743-57. PubMed ID: 16405510 [Abstract] [Full Text] [Related]
31. Transient global ischemia in rats yields striatal projection neuron and interneuron loss resembling that in Huntington's disease. Meade CA, Figueredo-Cardenas G, Fusco F, Nowak TS, Pulsinelli WA, Reiner A. Exp Neurol; 2000 Dec 06; 166(2):307-23. PubMed ID: 11085896 [Abstract] [Full Text] [Related]
32. Adenosine A2A receptor antagonism increases nNOS-immunoreactive neurons in the striatum of Huntington transgenic mice. Cipriani S, Bizzoco E, Gianfriddo M, Melani A, Vannucchi MG, Pedata F. Exp Neurol; 2008 Sep 06; 213(1):163-70. PubMed ID: 18586241 [Abstract] [Full Text] [Related]
33. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease. Starling AJ, André VM, Cepeda C, de Lima M, Chandler SH, Levine MS. J Neurosci Res; 2005 Nov 01; 82(3):377-86. PubMed ID: 16211559 [Abstract] [Full Text] [Related]
34. Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. Sepers MD, Raymond LA. Drug Discov Today; 2014 Jul 01; 19(7):990-6. PubMed ID: 24603212 [Abstract] [Full Text] [Related]
35. Normal sensitivity to excitotoxicity in a transgenic Huntington's disease rat. Winkler C, Gil JM, Araújo IM, Riess O, Skripuletz T, von Hörsten S, Petersén A. Brain Res Bull; 2006 Apr 14; 69(3):306-10. PubMed ID: 16564426 [Abstract] [Full Text] [Related]